default author photo

Lei Shi

China Pharmaceutical University

Nanjing Medical University

Jiangning

Nanjing, 211166

China

SCHOLARLY PAPERS

1

DOWNLOADS

27

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Indisulam Treatment Degrades Rbm39 and Inhibits Acute Megakaryoblastic Leukemia by Affecting Alternative Splicing of Zmynd8

Number of pages: 44 Posted: 19 Jun 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, China Pharmaceutical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Guizhou Medical University (Guiyang Medical University)
Downloads 27 (1,359,097)

Abstract:

Loading...

AMKL, alternative splicing, indisulam, RBM39